HAVCR2 and neoplasm: Additionally, tumor cells are able to reverse these mature, tumor-infiltrating, immune-active anti-tumor DCs into immune-suppressive, pro-tumor DCs by upregulating inhibitory receptors, including PD-1 and T cell immunoglobulin and mucin domain 3 (TIM-3) molecules on DCs [26].